Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Comment
Keywords:
covid, severity, polymorphismAbstract
n/a
References
Kaidashev I, Izmailova O, Shlykova O, Kabaliei A, Vatsenko A, Ivashchenko D, Dudchenko M, Volianskyi A, Zelinskyy G, Koval T, Dittmer U. Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population. Acta Biomed. 2023 Feb 13;94(1):e2023030. doi: 10.23750/abm.v94i1.13543.
Akcay OF, Yeter HH, Unsal Y, Yasar E, Gonen S, Derici U. Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in patients with renal replacement therapy. Hum Immunol. 2023 Feb 6:S0198-8859(23)00023-X. doi: 10.1016/j.humimm.2023.01.008. Online ahead of print.
Galán-Huerta KA, Zamora-Márquez MA, Flores-Pérez RO, Bocanegra-Ibarias P, Salas-Treviño D, Rivas-Estilla AMG, Flores-Treviño S, Lozano-Sepúlveda SA, Martínez-Acuña N, Camacho-Ortiz A, Pérez Alba E, Arellanos-Soto D, Nuzzolo-Shihadeh L, Garza-González E. Association of the Interleukin 1B-31*C Proinflammatory Allele with the Severity of COVID-19 Patients: A Preliminary Report. Viral Immunol. 2023 Feb 17. doi: 10.1089/vim.2022.0143. Online ahead of print.
Yaghoobi A, Lord JS, Rezaiezadeh JS, Yekaninejad MS, Amini M, Izadi P. TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population. PLoS One. 2023 Feb 16;18(2):e0281750.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 amnuay kleebayoon
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.